# Cleviprex

NDC: 18124-011
Generic name: clevidipine
Labeler / Manufacturer: Fresenius Kabi Austria GmbH
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: EMULSION
Routes: INTRAVENOUS
Marketing started: 20080915

FDA application: NDA022156

## Active ingredients

- CLEVIDIPINE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"18124-011"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=18124-011
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a6826aa3-fabb-4ff1-a7a3-cd4c34e3a330